501(c)(3) nonprofit · founded March 11, 2025
Korean device makers, entering the U.S. together
Founded by six Korean-American device and diagnostics companies already operating here, KAMDA shares what U.S. entry takes: FDA clearance, reimbursement, lab routes, partners.
Five barriers on the road to U.S. customers
The 2025 conference was built around them, in this order. Each had its own session, led by people who work on it in the U.S.
-
FDA clearance
Regulatory strategy, submissions and approval case studies.
- Session FDA Trends & Global Regulation Insights Haja Sittana El Mubarak, Ph.D., Wasela Diagnostics
- Session FDA Approval Strategies and Success Cases ByungSik Chang, Ph.D., Nano-Ditech
- Session FDA Preparation and Approval Strategy (CRO) JungYoup Han, Ph.D., Target Health
-
Reimbursement
How a cleared device gets paid for in the U.S. insurance system.
- Session Understanding the U.S. Healthcare Insurance System (Reimbursement system) MinSoo Seo, Taewoong Medical USA
-
Lab route (CLIA and LDT)
Offering a test through a CLIA-certified U.S. laboratory.
- Session Market Entry Strategy for the U.S. (Applications of LDT and CLIA Lab) JungHee Cho, Ph.D., LabG USA
-
Partners and acquisitions
Buying or partnering with a U.S. company to reach the market.
- Session Market Entry Strategy for the U.S. (Case Studies of U.S. Local Company Acquisitions) Curie Choi, Immunostics
-
Risk, IP and compliance
Contracts, liability and intellectual property once you sell here.
- Session Appropriate Risk Allocation in the FDA World Sung Park, Reed Smith
- Session Understanding IP and Compliance Eunjean Je, Morgan, Lewis & Bockius
October 23, 2025 · Reed Smith LLP, New York
The 1st KAMDA Conference
“Facing the Real Barriers: Korean Medical Device Companies' Strategic Entry into the U.S.”
- 9:30 AMRegistration and networking
- 10:30 AMWelcome and congratulatory remarks: Consulate General of Korea in New York, KHIDI, KOSME, Korea Venture Investment Corp.
- 11:00 AMOpening plenary and keynote: MARA Nanotech, Access Bio
- 1:00 PMSession I: Strategies and FDA Considerations for U.S. Market Entry
- 2:50 PMSession II: U.S. Market Entry Strategy and Insights
- 5:30 PMPanel: U.S. Market Entry and Medical Device Market Strategy
- 6:40 PMDinner and networking
Working with Korea's institutions in the U.S.
- Consulate General of the Republic of Korea in New YorkLeadership meetings with Consul General Kim Ui-hwan on April 22 and June 11, 2025; congratulatory remarks at the 2025 conference.
- Korea Health Industry Development Institute (KHIDI)Boston office at the founding and the 2025 conference; KHIDI USA announced the conference.
- Korea SMEs and Startups Agency (KOSME)New York Global Business Center at the founding and the 2025 conference.
- Korea Venture Investment Corp.New York office gave a congratulatory remark at the 2025 conference.
- Korea IVD association (KIVDA)Circulated the 2025 conference notice to its members.
Membership
Two ways to join
- Corporate member Medical device manufacturing, sales, or service companies. $500per year
- Special member (personal) Professionals, researchers, and academic staff, as well as professional services firms, engaged in or supporting the medical device industry. $20per year
Applications are reviewed by KAMDA. Payment instructions are sent after review.
Apply for membershipFounded on March 11, 2025 by
- Access Bio
- MARA Nanotech
- Nano-Ditech
- Immunostics
- LabGenomics (LAB.G USA)
- Target Health
Supported the 2025 conference
- Consulate General of the Republic of Korea in New York
- KOSME (Korea SMEs and Startups Agency)
- KHIDI (Korea Health Industry Development Institute)
- Reed Smith
- Bank of Hope
Covered by
- Korea Times USANovember 24, 2025
- KHIDI USASeptember 26, 2025
- Korea DailyJune 15, 2025
- New York IlboJune 14, 2025
- Consulate General of Korea in New YorkJune 12, 2025